Showing results (1531-1540 of 5,060) with videos related to

Sort By:
Pageof 506
Multiple Sclerosis and Related Disorders|April 2, 2019
A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesionNoriyuki Miyaue, Yuki Yamanishi, Satoshi Tada, et al.
Multiple Sclerosis and Related Disorders|August 23, 2019
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)Louis S Matza, Katie D Stewart, Glenn Phillips, et al.
Multiple Sclerosis and Related Disorders|September 14, 2019
Progressive dopaminergic defect in a patient with primary progressive multiple sclerosisValtteri Kaasinen, Juho Joutsa, Eero Rissanen, et al.
Multiple Sclerosis and Related Disorders|September 17, 2019
Atypical presentation of MOG-related disease: Slowly progressive behavioral and personality changes following a seizureÜnsal Yılmaz, Selvinaz Edizer, Çisel Yazan Songür, et al.
Multiple Sclerosis and Related Disorders|April 21, 2015
Early MRI activity predicts treatment nonresponse with intramuscular interferon beta-1a in clinically isolated syndromeR P Kinkel, J H Simon, P O'Connor, et al.
Multiple Sclerosis and Related Disorders|April 21, 2015
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosisSara La Gioia, Giuseppe Bacis, Aurelio Sonzogni, et al.
Multiple Sclerosis and Related Disorders|August 23, 2025
Efficacy and safety of ocrelizumab in pediatric multiple sclerosisAhmad Altelly, Azza Mahmoud, Victoria Mifsud, et al.
Multiple Sclerosis and Related Disorders|April 19, 2021
Smartphone applications to assess gait and postural control in people with multiple sclerosis: A systematic reviewLibak Abou, Ellyce Wong, Joseph Peters, et al.
Multiple Sclerosis and Related Disorders|September 3, 2025
Mesenchymal stem cells in clinical trials for multiple sclerosis: A systematic literature review and review of clinical trialsMohammad Ali Nahayati, Somayeh Ghavidel Yazdi, Mohammadreza Hassanisabzevar, et al.
Pageof 506